Heron Therapeutics
HRTX
#10276
Rank
โ‚ฌ43.79 M
Marketcap
0,23ย โ‚ฌ
Share price
-4.39%
Change (1 day)
-75.64%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2026 (TTM): -0,16ย โ‚ฌ

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -0,17ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,11ย โ‚ฌ a decrease over its 2024 EPS that were of -0,08204ย โ‚ฌ.

EPS history for Heron Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,16ย โ‚ฌ49.08%
2025-0,11ย โ‚ฌ33.33%
2024-0,08204ย โ‚ฌ
2022-1,58ย โ‚ฌ-23.11%
2021-2,05ย โ‚ฌ-10%
2020-2,28ย โ‚ฌ-0%
2019-2,28ย โ‚ฌ1.21%
2018-2,25ย โ‚ฌ
2016-4,15ย โ‚ฌ54.76%
2015-2,68ย โ‚ฌ1.73%
2014-2,63ย โ‚ฌ-16.23%
2013-3,15ย โ‚ฌ91.67%
2012-1,64ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
-1,12ย โ‚ฌ 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
0,32ย โ‚ฌ-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
2,36ย โ‚ฌ-1,463.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
-0,0000000000ย โ‚ฌ-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
-6,11ย โ‚ฌ 3,426.32%๐Ÿ‡บ๐Ÿ‡ธ USA